Neuroendocrine carcinoma of the posterior mediastinum: A possible primary lesion

Archives of Pathology and Laboratory Medicine

Volumn 123, Issue 10, 1999, Pages 933-936

  Horie, Yasushi ^a   Kato, Masako ^a  

^a TOTTORI UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CARCINOMA; CASE REPORT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDIASTINUM CANCER; NEUROENDOCRINE TUMOR; ULTRASTRUCTURE;

CARCINOMA, NEUROENDOCRINE; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; RIBS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032836589     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79:813-829.
2. Wick MR, Rosai J. Neuroendocrine neoplasms of the mediastinum. Semin Diagn Pathol. 1991;8:35-51.
3. Barnardo DE, Stavrou M, Bourne R, Bogomoletz WV. Primary carcinoid tumor of the mesentery. Hum Pathol. 1984;15:796-798.
4. 2-microglobulin to distinguish peripheral neuroepithelioma from neuroblastoma. Hum Pathol. 1993;24:880-885.
5. MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol. 1994;18:486-494.
6. MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor. Hum Pathol. 1996;27:408-416.